Bradykinin Promotes Cell Proliferation, Migration, Invasion, and Tumor Growth of Gastric Cancer Through ERK Signaling Pathway

@article{Wang2017BradykininPC,
  title={Bradykinin Promotes Cell Proliferation, Migration, Invasion, and Tumor Growth of Gastric Cancer Through ERK Signaling Pathway},
  author={Guojun Wang and Jun-feng Sun and Guanghui Liu and Yang Fu and Xiefu Zhang},
  journal={Journal of Cellular Biochemistry},
  year={2017},
  volume={118}
}
Bradykinin (BK) has been reported to be involved in the progression of diverse types of cancer. In the present study, we investigated the possible role of BK in cell proliferation, migration, invasion, and tumor growth of gastric cancer (GC). Cell proliferation was evaluated by MTT assays. Cell migration and invasion were assessed by Transwell assays. Tumor growth of nude mice was detected by establishing subcutaneous xenograft tumor model. Silencing of bradykinin B1 receptor (B1R) and the… Expand
Bradykinin promotes proliferation, migration, and invasion of cervical cancer cells through STAT3 signaling pathways
TLDR
BK promoted CC cell proliferation, migration, and invasion by binding to B2R via STAT3 signaling pathways, and was demonstrated that BK/B2R facilitated CC cell migration and invaded by upregulating the expression of the STAT3-regulated products MMP2 and MMP9. Expand
Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1
TLDR
The results indicate that bradykinin‐induced IL‐8 expression is dependent on B1R which causes phosphorylated STAT3 and acetylated SP‐1 to translocate to the nucleus, hence resulting in GBM migration. Expand
Placenta-specific protein 8 promotes the proliferation of lung adenocarcinoma PC-9 cells and their tolerance to an epidermal growth factor receptor tyrosine kinase inhibitor by activating the ERK signaling pathway.
TLDR
Results suggest that PLAC8 is involved in the regulation of proliferation of lung adenocarcinoma PC-9 cells and impacts their sensitivity to an EGFR-TKI, a epidermal growth factor receptor tyrosine kinase inhibitor. Expand
Mitochondria‐mediated apoptosis was induced by oleuropein in H1299 cells involving activation of p38 MAP kinase
TLDR
Results illustrated that oleuropein‐induced apoptosis via mitochondrial apoptotic cascade was activated by the p38 MAPK signaling pathway in H1299 cells, demonstrating potential application value in the treatment of lung cancer. Expand
Down-regulation of B2R contributes to preeclampsia by inhibiting human trophoblast cell invasion and angiogenesis.
TLDR
The decrease of B2R in placentas leads to the dysfunction of invasion, migration and angiogenesis of trophoblasts, which may be involved in the pathogenesis of PE. Expand
Serum bradykinin levels as a diagnostic marker in cervical cancer with a potential mechanism to promote VEGF expression via BDKRB2
TLDR
BK promotes the progression of CC by upregulating the expression of VEGF via BDKRB2 and subsequently facilitating angiogenesis and may notably improve the diagnostic efficacy when combined with SCCA. Expand
A modular map of Bradykinin-mediated inflammatory signaling network
TLDR
The development of a pathway resource of signaling events mediated by bradykinin will facilitate the identification of novel candidates as therapeutic targets for diseases associated with dysregulated bradykinsin signaling. Expand
Potentiation of B2 receptor signaling by AltB2R, a newly identified alternative protein encoded in the human bradykinin B2 receptor gene
TLDR
This study shows that BDKRB2 is a dual-coding gene and identifies AltB2R as a novel positive modulator of some B2R signaling pathways, which supports a new, unexpected alternative proteome for GPCRs, which opens new frontiers in fields of GPCR biology, diseases, and drug discovery. Expand
G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules
TLDR
The alterations of GPCRs activated by neurotransmitters or inflammation-associated molecules (bradykinin receptors, histamine receptors, chemokine receptors) in ovarian cancer are reviewed and their potential as histological biomarkers are discussed. Expand
Should safety of the flu vaccine for cancer patients be reexamined
TLDR
There is an urgent need for the reexamination of safety of influenza vaccine(s) in cancer patients after it was suggested that antibodies elicited with influenza vaccine could activate bradykinin receptor B2-associated signaling pathway. Expand
...
1
2
...

References

SHOWING 1-10 OF 57 REFERENCES
Bradykinin stimulates IL-6 production and cell invasion in colorectal cancer cells.
TLDR
It is demonstrated that BK increases IL-6 production via B2R and the ERK pathway, thereby contributing to the invasion and migration of colorectal cancer cells. Expand
Nitidine chloride inhibits ovarian cancer cell migration and invasion by suppressing MMP-2/9 production via the ERK signaling pathway.
TLDR
It was found that NC suppressed the proliferation, migration and invasion of A2780 ovarian cancer cells, and was able to downregulate phosphorylation of ERK. Expand
Bradykinin enhances cell migration in human chondrosarcoma cells through BK receptor signaling pathways
TLDR
Results indicated that BK enhances the migration of chondrosarcoma cells by increasing α2β1 integrin expression through the BK receptors/PLC/PKCδ/NF‐κB signal transduction pathway. Expand
Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture.
TLDR
The mitogenic effects of BK are retained in peritumour and tumour cells; hence, it is likely that BK has an important role in cancer endorsement and progression. Expand
Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues
TLDR
Results provide direct evidence that the BK B2 receptor is expressed in human cancer and experimental murine tumors, which suggests a potential role for BK in inducing pathologic signal transduction in cancer growth and progression, nitric oxide production and vascular permeability enhancement in tumors. Expand
Bradykinin induced mitogenesis of androgen independent prostate cancer cells.
TLDR
Bradykinin induces the proliferation of androgen insensitive prostate cancer cells and suggest a possible pathophysiological role for BK in prostate cancer. Expand
Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling.
TLDR
Results indicate that paeoniflorin exhibits a potential anticancer effect by enhancing human pancreatic cancer cell apoptosis via the suppression of MMP-9 and ERK signaling. Expand
Targeting the ERK signaling pathway in cancer therapy
TLDR
The possibility that combination of ERK pathway inhibitors and conventional anticancer drugs (cytotoxic agents) provides an excellent basis for the development of new chemotherapeutic strategies against cancer is discussed. Expand
Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer
TLDR
The knockdown of E-cadherin was sufficient to convert A549 NSCLC cells into mesenchymal type with the concurrent up-regulation of typical EMT inducers such as ZEB1 and TWIST1 and the results suggest that the EGFR-MEK/ERK/ZEB1/MMP2 axis is responsible for promoted invasion in EMT-induced NSCLCs. Expand
Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells.
TLDR
Activation of B(1)R is likely to enhance breast cancer cells invasiveness by releasing enzymes that degrade the extracellular matrix and thereby favor metastasis. Expand
...
1
2
3
4
5
...